Home
>
US Stocks
>
Kala Pharmaceuticals Inc
Kala Pharmaceuticals Inc
KALA

Kala Pharmaceuticals Inc (KALA)

$2.0432.67%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
1.88
Today Low/High
1.86 / 2.06
52 Week Low/High
$2.75 / $9.97
Market Cap
$191.02M

Company Details

Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of pre-clinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases.
Organisation
Kala Pharmaceuticals Inc
Headquaters
Watertown, Massachusetts, US
Employees
188
Industry
Health Technology
CEO
Mark Iwicki

Discover more

Frequently Asked Questions

What is Kala Pharmaceuticals Inc (KALA) share price today?

Can Indians buy Kala Pharmaceuticals Inc (KALA) shares?

How can I buy Kala Pharmaceuticals Inc (KALA) shares from India?

Can Fractional shares of Kala Pharmaceuticals Inc (KALA) be purchased?

What are the documents required to start investing in Kala Pharmaceuticals Inc (KALA) stocks?

We are a SEBI registered investement advisor